Chiesi USA Inc - Company Profile
Powered by 
All the sales intelligence you need on Chiesi USA Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Chiesi USA Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Chiesi USA Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Chiesi USA Inc (Chiesi USA) is a pharmaceutical company that develops, researches, produces, and commercializes therapies in cardiovascular, respiratory, neonatology, rare disease, and special care therapeutics. The company's product portfolio comprises of Cardene I.V. (nicardipine hydrochloride); Curosurf (poractant alfa); Zyflo (zileuton), Bethkis (tobramycin), Argatroban injection (Argatroban), Pertzye (pancrelipase), Kengreal (cangrelor), Cleviprex (clevidipine) and Retavase (reteplase). Its product pipeline encompasses drugs in key therapeutic areas of asthma, chronic obstructive pulmonary diseases, cardiovascular diseases, among others. It also offers products to retail pharmacy chains, wholesalers, group purchasing organizations, hospital systems, and specialty pharmacies. Chiesi USA is headquartered in Cary, North Carolina, the US.
Headquarters
United States of America
Address
Suite 600, 175 Regency Woods Place, Cary, North Carolina, 27518
Website
www.chiesiusa.com
Telephone
1 888 4666505
Industry
Pharmaceuticals and Healthcare
Chiesi USA Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Cardene I.V. (nicardipine hydrochloride) | Cardene I.V. |
| Curosurf (poractant alfa) | Pertzye |
| Pertzye (pancrelipase) | Zyflo |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Chiesi USA Inc | Eloxx Pharmaceuticals Inc | Genentech Inc | Lupin Pharmaceuticals Inc | Novartis Pharmaceuticals Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Cary | Watertown | San Francisco | Naples | East Hanover |
| State/Province | North Carolina | Massachusetts | California | Florida | New Jersey |
| No. of Employees | - | 18 | 13,500 | - | - |
| Entity Type | Private | Public | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jon Zwinski | Chief Executive Officer; General Manager | Senior Management | 2021 | - |
| John Hess | Senior Vice President - Chiesi Global Rare Diseases | Senior Management | - | - |
| Marc Claussen | Vice President - Business Excellence & Customer Experience | Senior Management | 2023 | - |
| Jason Beyer | Vice President - Business Unit Leader, US Special Care | Senior Management | 2021 | - |
| Gentry Lassiter | Managing Director - Senior Director - Corporate Affairs | Senior Management | 2024 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer